protein degraders arv-471 and arv-110
Published 3 years ago • 303 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
40:03
debbie chirnomas - dana-farber targeted degradation webinar series
-
2:46
rv-471: novel protac® estrogen receptor degrader, in er breast cancer
-
3:13
what is protein degradation?
-
35:14
102 - arvinas' pioneering protac tech to enhance cancer outcomes | interview with ceo john houston
-
5:30
genetic testing for advanced prostate cancer (royal stage) | prostate cancer staging guide
-
4:45
14-3-3 protein (2017)
-
2:10
targeted protein degradation | moa animation
-
1:48
prolaris testing in men with clinically localized prostate cancer
-
5:36
propel trial
-
5:04
ed hoppe - prolaris test for prostate cancer
-
4:43
adt as treatment in metastatic prostate cancer
-
1:37
dr. oh discusses the use of abiraterone and docetaxel in prostate cancer
-
4:58
proline metabolism
-
1:27
dr. haian fu continues to discuss the relationship between 1433 protein and cancer types
-
1:48
dr. ramos on the role of bcg in non-muscle invasive bladder cancer
-
1:25
dr. balar on imvigor 210 results for metastatic urothelial carcinoma
-
1:00
prolaris and questions about prostate cancer
-
2:12
abiraterone for metastatic, hormone sensitive, prostate cancer
-
2:23
metastatic cancer cells implode on protein contact